Stock Events

Stock Events

Femasys 

$2.98
100
-$0.08-2.61% Friday 20:00
+$0.00+0%Friday 23:30After hours

Statistics

Day High
2.99
Day Low
2.99
52W High
22.2
52W Low
2.02
Volume
1,904
Avg. Volume
-
Mkt Cap
24.96M
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

17NovExpected
Q3 2024
Q1 2025
Q2 2025
Q3 2025
Q1 2026
Q2 2026
Next
-1.33
-0.89
-0.44
0
Expected EPS
-0.466667
Actual EPS
N/A

Financials

-812.39%Profit Margin
Unprofitable
2020
2021
2022
2023
2024
2025
2.29MRevenue
-18.63MNet Income

Analyst Ratings

10.00Average Price Target
The highest estimate is 10.00.
From 2 ratings within the last 6 months. This is not an investment recommendation.
Buy
100%
Hold
0%
Sell
0%

People Also Follow

This list is based on the watchlists of people on Stock Events who follow FEMY. It's not an investment recommendation.
Microsoft
12
MSFT
NVIDIA
12
NVDA
Tesla
10
TSLA
AMD
10
AMD

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Cooper Companies
COO
Mkt Cap13.57B
The Cooper Companies, Inc. provides various healthcare products, including women's health and fertility solutions, making it a direct competitor in the reproductive health sector.
Medtronic
MDT
Mkt Cap120.46B
Medtronic plc offers medical technologies, services, and solutions, including those for gynecological surgery and health, competing in the broader women's health market.
Boston Scientific
BSX
Mkt Cap69.27B
Boston Scientific Corporation develops, manufactures, and markets medical devices used in various interventional medical specialties, including women's health.
ICU Medical
ICUI
Mkt Cap4.19B
ICU Medical, Inc. manufactures medical devices used in vascular therapy, oncology, and critical care applications, indirectly competing in the healthcare solutions sector.
Baxter International
BAX
Mkt Cap13.35B
Baxter International Inc. provides a portfolio of healthcare products, including medical devices and pharmaceuticals, competing in the broader healthcare market.
Dexcom
DXCM
Mkt Cap33.17B
DexCom, Inc. specializes in glucose monitoring systems but competes in the larger medical device market, indirectly affecting companies like Femasys.
Stryker
SYK
Mkt Cap116.27B
Stryker Corporation specializes in medical technologies, including surgical equipment and neurotechnology products, competing in the medical device industry.
Abbott Laboratories
ABT
Mkt Cap187.45B
Abbott Laboratories offers a broad range of healthcare products, including medical devices and diagnostics, competing in the global healthcare market.
Johnson & Johnson
JNJ
Mkt Cap663.28B
Johnson & Johnson engages in the research and development, manufacture, and sale of a broad range of healthcare products, indirectly competing across multiple sectors, including women's health.

About

Femasys Inc is a biomedical company focused on transforming women's healthcare by developing solutions and advancements providing clinical impact to address severely underserved areas. The company's mission is to provide women with minimally invasive, non-surgical product technologies, accessible in the office, improving patient care and overall health economics. Its product portfolio includes FemaSeed Intratubal Insemination, an infertility treatment; FemVue, a companion diagnostic for fallopian tube assessment via ultrasound; FemBloc, a clinical product candidate being developed as a permanent birth control; FemCerv, a tissue sampler for cervical cancer diagnosis; and FemCath and FemChec. Geographically, it derives key revenue from the United States and rest from international markets.
Show more...
CEO
Kathy Lee-Sepsick
Employees
54
Country
United States
ISIN
US31447E2046

Listings

XNAS
US
FEMY
BOATS
BOATS
FEMY.BOATS

0 Comments

Share your thoughts

FAQ

What is Femasys stock price today?▼
The current price of FEMY is $2.98 USD — it has decreased by -2.61% in the past 24 hours. Watch Femasys stock price performance more closely on the chart.
What is Femasys stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on XNAS exchange Femasys stocks are traded under the ticker FEMY.
Is Femasys stock price growing?▼
FEMY stock has fallen by -8.59% compared to the previous week, the month change is a +12.03% rise, over the last year Femasys has showed a -61.29% decrease.
What is Femasys market cap?▼
Today Femasys has the market capitalization of 24.96M
When is the next Femasys earnings date?▼
Femasys is going to release the next earnings report on November 17, 2026.
What were Femasys earnings last quarter?▼
FEMY earnings for the last quarter are -1.33 USD per share, whereas the estimation was -1.31 USD resulting in a -1.53% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Femasys revenue for the last year?▼
Femasys revenue for the last year amounts to 2.29M USD.
What is Femasys net income for the last year?▼
FEMY net income for the last year is -18.63M USD.
How many employees does Femasys have?▼
As of September 08, 2026, the company has 54 employees.
In which sector is Femasys located?▼
Femasys operates in the Health & Wellness sector.
When did Femasys complete a stock split?▼
The last stock split for Femasys was on June 08, 2026 with a ratio of 1:20.
Where is Femasys headquartered?▼
Femasys is headquartered in SUWANEE, United States.